Lsv Asset Management Pfizer Inc Transaction History

Lsv Asset Management

$48.3 Billion
Q1 2024

A detailed history of Lsv Asset Management transactions in Pfizer Inc stock. As of the latest transaction made, Lsv Asset Management holds 12,355,240 shares of PFE stock, worth $346 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

12,355,240

Previous 13,315,740 7.21%

Holding current value

$346 Million

Previous $383 Million 10.57%

% of portfolio

0.71%

Previous 0.84%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$25.89 - $29.73 $24.9 Million - $28.6 Million	-960,500 Reduced 7.21%	12,355,240 $343 Million
Q4 2023 Feb 06, 2024	SELL	$26.13 - $33.94 $21.4 Million - $27.8 Million	-819,728 Reduced 5.8%	13,315,740 $383 Million
Q3 2023 Nov 03, 2023	SELL	$32.09 - $37.51 $14.7 Million - $17.2 Million	-458,300 Reduced 3.14%	14,135,468 $469 Million
Q2 2023 Aug 02, 2023	SELL	$36.12 - $41.79 $97.3 Million - $113 Million	-2,693,950 Reduced 15.58%	14,593,768 $535 Million
Q1 2023 May 02, 2023	SELL	$39.39 - $51.28 $23.1 Million - $30.1 Million	-586,100 Reduced 3.28%	17,287,718 $705 Million

Q4 2022 Feb 08, 2023	SELL	$41.75 - $54.5 $52.5 Million - $68.6 Million	-1,258,327 Reduced 6.58%	17,873,818 $916 Million
Q3 2022 Nov 07, 2022	SELL	$43.76 - $53.42 $8.9 Million - $10.9 Million	-203,405 Reduced 1.05%	19,132,145 $837 Million
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $73.4 Million - $87 Million	-1,576,601 Reduced 7.54%	19,335,550 $1.01 Billion
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $28 Million - $34.7 Million	-612,497 Reduced 2.85%	20,912,151 $1.08 Billion
Q4 2021 Jan 28, 2022	SELL	$41.32 - $61.25 $21.1 Million - $31.2 Million	-509,900 Reduced 2.31%	21,524,648 $1.27 Billion
Q3 2021 Nov 04, 2021	BUY	$39.25 - $50.42 $7.69 Million - $9.88 Million	195,996 Added 0.9%	22,034,548 $948 Million
Q2 2021 Aug 04, 2021	SELL	$35.91 - $40.68 $24.3 Million - $27.5 Million	-675,415 Reduced 3.0%	21,838,552 $855 Million
Q1 2021 Apr 30, 2021	BUY	$33.49 - $37.77 $2.45 Million - $2.76 Million	73,099 Added 0.33%	22,513,967 $816 Million
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $48.5 Million - $61.7 Million	-1,449,900 Reduced 6.07%	22,440,868 $826 Million
Q3 2020 Oct 23, 2020	SELL	$31.75 - $37.25 $47.9 Million - $56.2 Million	-1,507,900 Reduced 5.94%	23,890,768 $877 Million
Q2 2020 Aug 05, 2020	SELL	$30.12 - $36.54 $42 Million - $50.9 Million	-1,394,000 Reduced 5.2%	25,398,668 $831 Million
Q1 2020 May 07, 2020	SELL	$27.03 - $38.62 $77.7 Million - $111 Million	-2,874,739 Reduced 9.69%	26,792,668 $875 Million
Q4 2019 Feb 10, 2020	SELL	$32.92 - $37.36 $53.7 Million - $60.9 Million	-1,630,901 Reduced 5.21%	29,667,407 $1.16 Billion
Q3 2019 Nov 07, 2019	SELL	$32.49 - $42.13 $41.9 Million - $54.3 Million	-1,289,957 Reduced 3.96%	31,298,308 $1.12 Billion
Q2 2019 Aug 08, 2019	SELL	$36.98 - $41.52 $39.3 Million - $44.1 Million	-1,062,215 Reduced 3.16%	32,588,265 $1.41 Billion
Q1 2019 May 07, 2019	SELL	$37.5 - $41.2 $50.5 Million - $55.5 Million	-1,347,700 Reduced 3.85%	33,650,480 $1.43 Billion
Q4 2018 Feb 05, 2019	SELL	$38.47 - $43.86 $66.4 Million - $75.7 Million	-1,726,117 Reduced 4.7%	34,998,180 $1.53 Billion
Q3 2018 Nov 06, 2018	SELL	$34.47 - $41.81 $1.73 Million - $2.1 Million	-50,294 Reduced 0.14%	36,724,297 $1.62 Billion
Q2 2018 Aug 08, 2018	BUY	$32.98 - $35.16 $32.1 Million - $34.2 Million	973,497 Added 2.72%	36,774,591 $1.33 Billion
Q1 2018 May 04, 2018	BUY	$31.91 - $37.02 $46 Million - $53.3 Million	1,440,402 Added 4.19%	35,801,094 $1.27 Billion
Q4 2017 Feb 01, 2018	SELL	$33.26 - $35.29 $2.73 Million - $2.9 Million	-82,182 Reduced 0.24%	34,360,692 $0
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $1.07 Billion - $1.18 Billion	34,442,874	34,442,874 $1.23 Billion

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.

Account

Lsv Asset Management Pfizer Inc Transaction History